Long J, Luo G P, Xiao Z W, et al. Cancer statistics: Current diagnosis and treatment of pancreatic cancer in Shanghai, China[J]. Cancer Letters, 2014, pii: S0304-3835(14)00030-5.
[2]
Wang L, Dong J, Ouyang W, et al. Anticancer effect and feasibility study of hyperthermia treatment of pancreatic cancer using magnetic nanoparticles[J]. Oncology Reports, 2012, 27(3): 719-726.
[3]
Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA: A Cancer Journal for Clinicians, 2010, 60(5): 277-300.
[4]
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012[J]. CA: A Cancer Journal for Clinicians, 2012, 62(1): 10-29.
[5]
Parchur A K, Ansari A A, Singh B P, et al. Enhanced luminescence of CaMoO4: Eu by core@shell formation and its hyperthermia study after hybrid formation with Fe3O4: Cytotoxicity assessment on human liver cancer cells and mesenchymal stem cells[J]. Integrative Biology (Cambridge), 2014, 6(1): 53-64.
[6]
Taratula O, Dani R K, Schumann C, et al. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells[J]. International Journal of Pharmaceutics, 2013, 458(1): 169-180.
[7]
Oliveira T R, Stauffer P R, Lee C T, et al. Magnetic fluid hyperthermia for bladder cancer: A preclinical dosimetry study[J]. International Journal of Hyperthermia, 2013, 29(8): 835-844.
[8]
Portela A, Vasconcelos M, Fernandes M H, et al. Highly focalised thermotherapy using a ferrimagnetic cement in the treatment of a melanoma mouse model by low temperature hyperthermia[J]. International Journal of Hyperthermia, 2013, 29(2): 121-132.
[9]
Kobayashi D, Kawai N, Sato S, et al. Thermotherapy using magnetic cationic liposomes powerfully suppresses prostate cancer bone metastasis in a novel rat model[J]. Prostate, 2013, 73(9): 913-922.
[10]
Jordan A. First clinical experience with magnetic field hyperthermia (MFH) at the university clinic charite in Berlin[C]. 5th International Conference on the Scientific and Clinical Application for Mangetic Carriers, 2004, May 20-22, Lyon, France.
[11]
Maier-Hauff K, Ulrich F, Nestler D, et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron- oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme[J]. Journal of Neurooncology, 2011, 103(2): 317-324.
[12]
Johannsen M, Thiesen B, Wust P, et al. Magnetic nanoparticle hyperthermia for prostate cancer[J]. International Journal of Hyperthermia, 2010, 26(8): 790-795.
[13]
van Landeghem F K, Maier-Hauff K, Jordan A, et al. Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles[J]. Biomaterials, 2009, 30(1): 52-57.
[14]
Ouyang W, Gao F, Wang L, et al. Thermoseed hyperthermia treatment of mammary orthotopic transplantation tumors in rats and impact on immune function[J]. Oncology Reports, 2010, 24(4): 973-979.
